Despite accelerating revenue, the shares were slaughtered on new financing. From a revenue growth perspective, things look very good, but the company is still bleeding cash and that’s not going to change anytime soon. If operational cost don’t increase a whole lot more from the current $100M level, the company has cash for another 5-6 […]
Entries Tagged as 'SENS'
July 20th, 2019 · Comments Off on Senseonics Is Hitting An Inflection Point
April 14th, 2019 · Comments Off on Senseonics Will Still Need To Go Back To The Markets
Senseonics’ Eversence continuous glucose monitoring product provides the company with a tremendous opportunity, but developing this market doesn’t come cheap. In order to accelerate acceptance, Senseonics is investing in a new program, but in the short term this is adding to costs. In our view, the company will still have substantial cash needs next year, […]
September 20th, 2018 · Comments Off on Senseonics Revenues Are Set To Explode
Their continuous glucose monitoring sensor Eversense is set to take the considerable market share and even broaden it as it has important advantages. So expect some explosive revenue growth in the coming years. However, the company will still produce substantial losses and cash burn and it’s difficult to see with any kind of precision when […]